Chase AIPricingFAQs
Display currency
Loading news…

Sonus Pharmaceuticals

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Bothell, Washington, United States Founded 1991 1-10 employees For Profit

Sonus Pharmaceuticals, Inc. engages in the development of oncology drugs for the treatment of cancer primarily in the United States.

Sonus Pharmaceuticals was acquired by OncoGenex in 2008.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
1
Monthly Visits
Available in Pro
Contacts
0

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
3
IT spend
$2M

Company Info

Founded
1991
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
HQ
Bothell, Washington, United States
Region
Greater Seattle Area, West Coast, Western US
Exit date
May 28, 2008

Signals & Scores

Heat score
High
Growth score
High
Trend (7d)
-0.1
Trend (30d)
-1
Trend (90d)
-1.7

Acquisitions by Sonus Pharmaceuticals

Loading columns…
0 of 0Show
Page 1 / 1

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Sonus Pharmaceuticals

Loading news…

FAQs about Sonus Pharmaceuticals

People who checked this page also checked these

Sectors Sonus Pharmaceuticals invests & acquires in

M&A by year

Browse the full Acquirezy directory.
Sonus Pharmaceuticals - Company Profile, Full Acquisitions List, Funding and Investments